Canada markets closed

SVRA Aug 2024 2.500 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
2.65000.0000 (0.00%)
As of 03:17PM EDT. Market open.
Full screen
Loading interactive chart...
  • Business Wire

    Savara to Present at the Jefferies Global Healthcare Conference

    LANGHORNE, Pa., May 29, 2024--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 5, 2024 at 7:00am PT/10:00am ET. A live webcast of the fireside chat will be available on Savara’s website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days.

  • Business Wire

    Savara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024

    LANGHORNE, Pa., May 19, 2024--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego, CA. Savara’s partner, Trillium Health LLC, presented a poster on the laboratory blood test that was recently developed to aid in the diagnosis of aPAP.

  • Business Wire

    Savara Announces New Employment Inducement Grant

    AUSTIN, Texas, May 16, 2024--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to a new employee.